Associated Papers
Paraoxonase 1 polymorphisms and their relationship with gastric cancer risk: a biochemical perspective on oxidative stress.
Najafi E et al.
Molecular Biology Reports, 2025
Recent Insights on Genetic Testing in Primary Prostate Cancer.
Kafka M et al.
Molecular Diagnosis & Therapy, 2021
Paraoxonase Role in Human Neurodegenerative Diseases.
Reichert CO et al.
Antioxidants (basel, Switzerland), 2020
Clinical significance of PON1 L55M, Q192R and I102V polymorphisms and their association with prostate cancer risk in Polish men.
Unknown Author
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists, 2020
Genetic polymorphisms in amyotrophic lateral sclerosis: Evidence for implication in detoxification pathways of environmental toxicants.
Dardiotis E et al.
Environment International, 2018
CYP/PON genetic variations as determinant of organophosphate pesticides toxicity.
Kaur G et al.
Journal of Genetics, 2017
Q192R and L55M Polymorphisms of Paraoxonase 1 Gene in Chronic Myelogenous Leukemia and Chronic Lymphocytic Leukemia.
Tomatir AG et al.
Anticancer Research, 2015
Effects of paraoxonase 1 activity and gene polymorphisms on long-term pulmonary complications of sulfur mustard-exposed veterans.
Taravati A et al.
International Immunopharmacology, 2013
Assessing the relationship of paraoxonase-1 Q192R polymorphisms and the severity of lung disease in SM-exposed patients.
Golmanesh L et al.
Immunopharmacology and Immunotoxicology, 2013
Common genetic variants in the myeloperoxidase and paraoxonase genes and the related cancer risk: a review.
Yuzhalin AE et al.
Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews, 2012
SNPs associated with prostate cancer risk and prognosis.
Naylor SL
Frontiers in Bioscience : a Journal and Virtual Library, 2007
A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis.
Morahan JM et al.
Neurotoxicology, 2007
Systematic replication study of reported genetic associations in prostate cancer: Strong support for genetic variation in the androgen pathway.
Lindström S et al.
The Prostate, 2006
Prevalent mutations in prostate cancer.
Dong JT
Journal of Cellular Biochemistry, 2006
[Chimpanzee genome sequencing and comparative analysis with the human genome].
Watanabe H et al.
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme, 2006
Comparative analysis of cancer genes in the human and chimpanzee genomes.
Puente XS et al.
Bmc Genomics, 2006
Association of CYP17, GSTP1, and PON1 polymorphisms with the risk of prostate cancer.
Antognelli C et al.
The Prostate, 2005
Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?
Mackness M et al.
Free Radical Biology & Medicine, 2004
[Genetic susceptibility to prostate cancer].
Cussenot O et al.
Medecine Sciences : M/s, 2004
An evolutionary perspective on single-nucleotide polymorphism screening in molecular cancer epidemiology.
Zhu Y et al.
Cancer Research, 2004
New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men.
Marchesani M et al.
Journal of the National Cancer Institute, 2003